Figure 5.
Results are shown as effects of curcumin on IκB degradations. Lanes 1, 2: 50% ethanol group; lane 3: TNBS group; lane 4: 0.5% SASP group; lane 5: 2.0% curcumin preventive group; lane 6: 2.0% curcumin therapeutic group.
Results are shown as effects of curcumin on IκB degradations. Lanes 1, 2: 50% ethanol group; lane 3: TNBS group; lane 4: 0.5% SASP group; lane 5: 2.0% curcumin preventive group; lane 6: 2.0% curcumin therapeutic group.